Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Double-Blind Clinical Trial of Tongjiang Granule in the Treatment of Patients With Overlapping Gastrointestinal Symptoms of Nonerosive Reflux Disease(NERD) and Epigastric Pain Syndrome(EPS)

NCT05312463 is registered in ClinicalTrials.gov with Xiyuan Hospital of China Academy of Chinese Medical Sciences as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05312463 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Double-Blind Clinical Trial of Tongjiang Granule in the Treatment of Patients With Overlapping Gastrointestinal Symptoms of Nonerosive Reflux Disease(NERD) and Epigastric Pain Syndrome(EPS)
Lead sponsor
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Phase
Phase 1/2
Overall status
Unknown status
Start date
March 26, 2022
Completion date
October 31, 2024
Enrollment
228 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

functional dysphonia, gastroesophageal reflux